Spire Healthcare (LSE:SPI) has confirmed that discussions with private equity groups Bridgepoint and Triton regarding a potential takeover have concluded, reducing the number of parties involved in its ongoing strategic review. The company said it remains in talks with other potential bidders and continues to explore options that could enhance long-term value for shareholders.
Spire noted that it will update the market if and when appropriate as the review progresses. The company also remains in a formal offer period under UK takeover regulations, meaning increased disclosure requirements apply to significant shareholders and other market participants.
Management emphasised that there is no certainty a formal offer will emerge from the process, nor clarity on the terms of any potential transaction should one materialise. As such, investors are being advised that the review could still result in a range of outcomes.
Spire Healthcare’s outlook is supported by recovering revenues and consistently positive cash generation, though these strengths are offset by relatively high leverage and weaker conversion of earnings into net profit. Technical indicators remain soft, with the share price trading below key moving averages, while valuation metrics appear stretched given a relatively high P/E ratio and modest dividend yield.
More about Spire Healthcare
Spire Healthcare Group is one of the UK’s leading independent healthcare providers, operating 38 hospitals and more than 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. The group works with more than 8,700 consultants and treats over one million patients each year, and it is the country’s largest private provider of knee and hip replacement procedures.
Leave a Reply